CTXR: the cashflow

MyFinsight

The latest financial statement is for the quarter ending 2025-12-31.

Unit: Dollar

Cash Flow	2025-12-31	2025-09-30	2025-06-30
Net loss	-9,393,889	-8,743,646	-30,996,623
Amortization of operating lease right-of-use asset	-	62,038	152,212
Stock-based compensation expense	4,280,227	2,889,762	7,946,529
Issuance of common stock for services	107,510	26,600	0
Issuance of common stock warrant	68,597	-	-
Amortization of in-process research and development	573,438	-	-
Depreciation	-	-	0
Amortization (accretion) of operating lease right-of-use asset	-16,483	-	-
Deferred income tax expense	264,240	264,240	792,720
Accounts receivable, net of allowances	4,049,111	-	-
Inventory	352,649	3,709,006	8,940,201
Prepaid expenses	2,139,797	1,451,034	-1,386,824
Accounts payable	-2,672,280	3,599,650	5,166,831
Accrued expenses	503,054	-4,333,422	8,506,648
Accrued compensation	-198,052	-417,594	1,481,023
Operating lease liability	16,373	-68,378	-167,911
Net cash used in operating activities	-13,008,822	-11,880,790	-14,671,948
License fee payments	4,400,000	5,750,000	-
Net cash used in investing activities	-4,400,000	-5,750,000	-
Proceeds from note payable and advance from employee	-	0	1,300,000
Proceeds from sale of series a preferred stock	-	-	100
Repayment of advance from employee	-	0	300,000
Net proceeds from common stock offerings	20,877,925	15,793,954	16,509,194
Redemption of series a preferred stock	-	-	100
Net cash provided by financing activities	20,877,925	15,793,954	17,509,194
Net change in cash and cash equivalents	3,469,103	-1,836,836	2,837,246
Cash and cash equivalents at beginning of period	4,252,290	3,251,880	-
Cash and cash equivalents at end of period	7,721,393	4,252,290	-

Unit: Dollar